This NDC is on FDA's drug shortage list (posted Mar 10, 2023)
Product Information
CLONAZEPAM 0.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0197 per EA under NDC 59651072201. Its NADAC has been published 150 times since Oct 11, 2023.
FDA first approved this application on Oct 5, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651072201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA075150FDA Approved
10/5/1998
TE Code
AB
On Market Since
1/17/2023
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 25.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0197 per EA |
|---|---|
| All-time high | $0.0284 (Oct 16, 2024) |
| All-time low | $0.0174 (Nov 20, 2024) |
| 52-week high | $0.0224 |
| 52-week low | $0.0197 |
| Median price | $0.0218 |
| Average price | $0.0225 |
| Largest weekly change | -34.1% (Nov 20, 2024) |
| Weeks tracked | 150 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0197 per EA (NDC 59651072201), effective Aug 19, 2026.
How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has declined 25.3%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?
Since Oct 11, 2023, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0284 (Oct 16, 2024), with a median of $0.0218 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLONAZEPAM 0.5 MG TABLET?
CLONAZEPAM 0.5 MG TABLET (NDC 59651072201) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Is CLONAZEPAM 0.5 MG TABLET in shortage?
Yes — NDC 59651072201 is currently listed in FDA's drug shortage database (posted Mar 10, 2023).